Skip to main content
. 2024 Dec 13;12(12):1407. doi: 10.3390/vaccines12121407

Table 5.

Hesitancy outcomes for patient respondents based on demographics.

VHS-Total VHS-COVID VHS-Influenza
Score, Mean (Median) p-Value Score, Mean (Median) p-Value Score, Mean (Median) p-Value
Patient Gender
 Male 37 (31) 0.15 35 (31) 0.24 40 (36) 0.24
 Female 20 (16) 17 (11) 27 (25)
Parental Education
 High 22 (16) 0.8 20 (11) 0.65 28 (28) 0.62
 Low 31 (17) 11 (11) 36 (33)
Type of Treatment Received
 Cancer 20 (16) 0.005 16 (11) 0.016 25 (11) 0.003
 BMT 64 (59) 67 (72) 74 (72)
Treatment Phase
 Active 30 (20) 0.4 16 (8) 0.38 42 (33) 0.15
 Surveillance 28 (16) 30 (11) 28 (28)
Cancer Type
 Leukemia/lymph 17 (16) 0.83 13 (11) 0.74 20 (19) 0.49
 Brain/solid 23 (16) 19 (11) 29 (28)
Relapse status
 Yes 23 (16) 0.9 19 (6) 0.52 35 (33) 0.25
 No 22 (16) 19 (11) 25 (25)
School
 Public school 22 (16) 0.09 18 (11) 0.10 28 (28) 0.08
 Other 51 (43) 54 (50) 56 (44)
Household Income
 High 25 (16) 0.52 21 (11) 0.81 28 (28) 0.20
 Low 30 (30) 28 (28) 39 (39)
COVID Vaccine status (self)
 0 or 1 dose 66 (64) 0.02 67 (50) 0.02 67 (67) 0.03
 ≥2 doses 22 (16) 16 (11) 29 (28)
Influenza Vaccine status (self)
 ≤2 doses in the last 5 years 28 (17) 1.0 25 (11) 0.77 33 (33) 0.88
 3–5 doses in the last 5 years 29 (18) 23 (11) 36 (28)

Numbers do not total 100% due to partial survey completion or rounding. Parental education level collapsed into high (college diploma, university degree, master’s, Ph.D. or professional degree) and low (high school diploma or below). Patient school collapsed into public and other (private, homeschool, not school age, other). Household income collapsed into high (>$50,000/year) and low (<$50,000/year).